Mindray(SZ:300760) Zheng Quan Shi Bao Wang·2025-11-27 11:56Core Viewpoint - The chairman of Mindray Medical, Li Xiting, has demonstrated confidence in the company's intrinsic value and future development by initiating a share buyback and announcing a subsequent buyback plan [1][2] Group 1: Shareholding and Buyback Plans - On November 27, Li Xiting purchased 152,300 shares at an average price of 196.862 yuan per share, totaling approximately 29.99 million yuan [1] - Following this purchase, the combined shareholding of Li Xiting and his concerted action partner, Xu Hang, increased to 51.48% [2] - Li Xiting plans to continue buying shares over the next six months starting from November 27, 2025, with a total budget of 200 million yuan, without a set price range [2] Group 2: Previous Buyback Activities - Mindray Medical has previously executed multiple share buyback plans since its A-share listing, including a 1 billion yuan buyback plan initiated on August 26, 2021, which was completed by September 1 of the same year [2] - In early 2022, the company announced another buyback, acquiring 3.2499 million shares at an average price of 307.595 yuan per share, with a total expenditure of approximately 1 billion yuan [2] Group 3: Employee Stock Ownership Plan - In 2022, Mindray Medical introduced its first employee stock ownership plan since its listing in 2018, targeting core employees and technical backbones, excluding senior management [3] - The total investment for this plan was capped at 152 million yuan, with the final actual subscription amount matching this limit [3]